Jinshiya Pharmaceutical: Subsidiary's Sodium Diclofenac Sustained Release Tablets Pass Generic Drug Consistency Assessment.

Jinshiya Pharmaceutical announced that the sustained-release sodium diclofenac tablets of its wholly-owned second-level subsidiary Zhejiang Dier Pharmaceutical Co., Ltd. have passed the generic drug quality and efficacy consistency evaluation. The drug registration standard number is YBH28882025, and the original drug approval number is National Drug Approval H20083921. Zhejiang Dier Pharmaceutical Co., Ltd., the holder of the drug marketing authorization, has received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration.